Infectious Diseases
News
FDA approves new treatment for adults with HCV
Results of two trials showed that 96%-97% of patients who received Vosevi had no virus detected in the blood 12 weeks after finishing treatment
From the Journals
New tool predicts antimicrobial resistance in sepsis
Here’s how to predict antibiotic resistance in sepsis patients infected with gram-negative bacteria.
Conference Coverage
Adding cefepime to vancomycin improved MRSA bacteremia outcomes
NEW ORLEANS – Do cefepime and vancomycin have a synergistic relationship useful for shortening MRSA bloodstream infections?
From the Journals
Liver cancer risk lower after sustained response to DAAs
DAAs may reduce prevalence of hepatocellular carcinoma among patients with hepatitis C.
From the Journals
Study: No increased mortality with ACA-prompted readmission declines
Reductions in 30-day hospital readmission rates among Medicare fee-for-service beneficiaries are weakly but significantly correlated with...
Conference Coverage
Antiviral shows early promise for treatment of Zika infection
Anti-HCV drug prevents maternal-fetal vertical transmission in mouse model.
Conference Coverage
Preventing Zika in pregnancy: What you need to know
DENVER – Much of the United States is vulnerable during mosquito season.
Conference Coverage
Asymptomatic maternal Zika infection doesn’t dampen birth defect risk
“This is worse than thalidomide.”
Conference Coverage
Vancomycin research reveals reasons for readmissions and prolonged stays
Which patients treated with vancomycin for acute bacterial skin and skin structure infections get readmitted to the hospital within 30 days and/or...
From the Journals
Subsequent squamous cell carcinoma risk higher in HIV patients with low CD4 count
HIV-infected people who have had a previous nonmelanoma skin cancer are at greater risk of subsequent SCC.
From the Journals
New C. difficile drug shows promise
The antibiotic ridinilazole proved noninferior to vancomycin for treatment of Clostridium difficile infection, according to a new study...